• OPEN AN ACCOUNT
Indian Indices
Sensex
72,911.40 528.93
( 0.73%)
Global Indices
Nasdaq
51,284.68 86.72
(0.17%)
Dow Jones
7,793.50 49.78
(0.64%)
Hang Seng
70,716.70 769.84
(1.10%)
Nikkei 225
10,489.44 27.49
(0.26%)
Forex
USD-INR
95.96 -0.21
(-0.22%)
EUR-INR
107.98 -0.51
(-0.47%)
GBP-INR
127.02 -0.14
(-0.11%)
JPY-INR
0.61 0.00
(-0.10%)

EQUITY - MARKET SCREENER

Rossari Biotech Ltd
Industry :  Chemicals
BSE Code
ISIN Demat
Book Value()
543213
INE02A801020
219.9684611
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ROSSARI
15.81
2384.99
EPS(TTM)
Face Value()
Div & Yield %
27.24
2
0.12
 

CreditAccess Grameen successfully raises Rs 300 cr via NCDs
Sep 03,2026

CreditAccess Grameen has successfully raised Rs 300 crore in September 2026 through private placement of non-convertible debentures (NCDs). The issue launched was fully subscribed and bilaterally placed with Barclays Bank PLC, a qualified institutional buyer.

The Company continues to tap the private placement NCD route to fund the growth of its lifecycle credit suite for low-middle income households across rural and semi-urban India.

The NCDs are senior, secured, rated, listed, and redeemable in nature. The NCDs were issued in two tranches – i) Rs 100 crore with a tenure of 24 months carrying a fixed rate coupon of 9.15% per annum and ii) Rs 200 crore with a tenure of 36 months carrying a fixed rate coupon of 9.25% per annum. The coupon on both tranches is payable annually, with the principal repayable as a bullet payment at the end of the respective tenures.